Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
IssueQ12020
Sort By
Newest First
1 / 3
1 / 3
M&A
M&A: Fundamental to Pharma Industry Growth
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q1-20-NI-002
Mar 20, 2020
Nice Insight Overview
Understanding a Dynamic Industry Through Mergers and Acquisitions
Nigel Walker
Nice Insight
PAP-Q1-20-NI-001
Mar 19, 2020
Pharmaceutics Know-How
Pharmaceutics Know-How and Service Excellence to Re-Energize a CDMO
Kurt R. Nielsen, Ph.D.
Pii
PAP-Q1-20-CL-001
Mar 19, 2020
AAV Vector Production
Challenges to Process Validation for Viral Vectors
Kyle Zingaro, Ph.D.; Deborah Mar Begos; Todd Miller
Thermo Fisher Scientific
PAP-Q1-20-CL-002
Mar 19, 2020
CDMO Leadership
A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership
Frank Mathias, Ph.D.
Rentschler Biopharma SE
PAP-Q1-20-CL-003
Mar 19, 2020
Excipients
New Mannitol Formulations Are a Gem of a Collection
Graeme MacLeod; Bill McCarthy
SPI Pharma
PAP-Q1-20-CL-004
Mar 19, 2020
Virtual Panel
Leveraging a Biomanufacturing Legacy to Support New Business
Grifols Recombinant Protein CDMO
PAP-Q1-20-CL-005
Mar 19, 2020
Microbiome
Reflections on a 10-Year Journey in the Microbiome
Aaron B. Cowley, Ph.D.
Arranta Bio
PAP-Q1-20-CL-006
Mar 19, 2020
Business Models
CDMO Services Designed to Support Evolving Pharma Business Models
Patrice Martin
Servier
PAP-Q1-20-CL-007
Mar 19, 2020
Small-Volume Manufacturing
Benefits of Integrated Small-Volume Manufacturing Capabilities
James J. Springer, Ph.D.; Mitch Kenyon; Tyler Kerr; James Goodwin
Albemarle Fine Chemistry Services
PAP-Q1-20-CL-008
Mar 19, 2020
Tracking and Visibility
Proprietary Tracking and Visibility Tools Ensure Secure Transportation
Marc Boyle
Boyle Transportation
PAP-Q1-20-CL-009
Mar 19, 2020
Continuous Improvement
The Critical Role of Continuous Improvement in Parenteral Drug Manufacturing
Antonio A. Gomez
Grifols
PAP-Q1-20-CL-010
Mar 19, 2020
Drug Development
A New Approach for Diseases Associated with BH4-Dependent Enzymatic Pathways
Jonathan Reis, Ph.D.
PAP-Q1-20-CL-011
Mar 19, 2020
Amorphous Solid Dispersion
Small-Scale Screening Technology for Amorphous Solid Dispersion Development
Daniel Treffer, Ph.D.
MeltPrep
PAP-Q1-20-CL-012
Mar 19, 2020
Bioinformatics
Leveraging Bioinformatics for Nontraditional Drug Discovery
Ben Zeskind, Ph.D
Immuneering Corporation
PAP-Q1-20-CL-013
Mar 19, 2020
RNA Biomarkers
RNA Biomarkers for Early Lung Cancer Diagnosis
Ron Andrews
OncoCyte
PAP-Q1-20-CL-014
Mar 19, 2020
Immune Therapies
An R&D Engine for Novel Immune Therapies
Alexis Peyroles
OSE Immunotherapeutics
PAP-Q1-20-CL-015
Mar 19, 2020
In Conversation
NantKwest — Harnessing Natural Killer Cells to Treat Cancer
Emilie Branch; Gary Lord; Dago Caceres; Patrick Soon-Shiong, M.D.
Pharma's Almanac
PAP-Q1-20-CL-016
Mar 19, 2020
Process Engineering
Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs Through Process Engineering and Technological Innovation
Scott Doncaster; Clarke MacDonald
BIOVECTRA
PAP-Q1-20-CL-017
Mar 19, 2020
Cancer Screening
Innovating to Increase Adherence for Colon Cancer Screening
Alex Ovadia
Check-Cap
PAP-Q1-20-CL-018
Mar 19, 2020